Hydralyte reaches first monthly EBITDA profit as restructuring gains emerge

Hydralyte LLC reaches monthly EBITDA profit

Hydralyte LLC, the operating business of The Hydration Pharmaceuticals Company (ASX:HPC), moved into positive monthly EBITDA in August, posting a A$6,055 profit compared with a A$217,210 loss a year earlier. It was the clearest marker yet in the company’s July and August trading update that its restructuring programme is affecting the underlying economics of the business.

The improvement was not confined to one month. Hydralyte LLC’s combined EBITDA loss for July and August fell to A$10,216 from A$468,688 in the corresponding period of 2025, an improvement of approximately 98%. July’s underlying loss was A$16,271, down from A$251,478.

Consolidated losses remain, but the gap is narrowing

At group level, HPC still reported a consolidated EBITDA loss, although the deficit contracted materially. The two-month loss fell to A$175,090 from A$688,743, a 75% year-on-year reduction. August accounted for much of the acceleration: the monthly consolidated EBITDA loss narrowed to A$55,594 from A$318,064, an 83% improvement.

July was also substantially better, with the consolidated EBITDA loss declining to A$119,496 from A$370,679. The gap between the underlying operating result and the consolidated figure indicates that corporate expenses continued to weigh on the group, even as Hydralyte LLC approached break-even across the two-month period.

Margins show the effect of restructuring

August gross margin increased to 73.3%, compared with 66.2% in August 2025. The company attributed the change to its 2026 restructuring and operating initiatives, alongside a lower operating cost base and tighter operating discipline. It also reported record contribution margin performance across July and August, although the announcement did not disclose the contribution margin figures.

The numbers offer a more useful test of the restructuring than headline claims alone: costs have fallen, margins have improved and the operating subsidiary has briefly crossed into EBITDA profit. They do not yet establish consolidated profitability, positive cash flow or a sustained monthly trend. The company’s forward-looking statements remain subject to risks and uncertainties, and the figures in this update have not been audited.

The next test is consistency

Chairman Nick Berry said the board remained focused on maintaining operating discipline and building on the improved margin and cost structure. For HPC, the practical question is now whether August’s A$6,055 underlying EBITDA profit can be repeated while corporate costs are absorbed at group level. A run of positive operating months would carry considerably more weight than a single favourable print.